Prestwick Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Prestwick Pharmaceuticals Ownership

Who owns Prestwick Pharmaceuticals?

Prestwick Pharmaceuticals is owned by Biovail. It was acquired on September 17, 2008.

Prestwick Pharmaceuticals Business Overview

Where is Prestwick Pharmaceuticals headquartered?

Prestwick Pharmaceuticals is headquartered in Washington, District of Columbia.

How many employees does Prestwick Pharmaceuticals have?

Prestwick Pharmaceuticals has 29 employees.

What sector is Prestwick Pharmaceuticals in?

Prestwick Pharmaceuticals is a life science company.

When was Prestwick Pharmaceuticals founded?

Prestwick Pharmaceuticals was founded in 2002.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

Prestwick Pharmaceuticals, Inc.

1825 K Street NW, Suite 1475,
Washington, District of Columbia 20006
United States,
(202) 296-1400

Prestwick Pharmaceuticals, Inc. is a privately held, U.S.-based pharmaceutical company that holds the Canadian and U.S. licensing rights to Xenazine(R) (tetrabenazine tablets).


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.